← Eichor
Study identifier: NCT00081523 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Natural History of Sickle Cell Disease

Condition: Pain Crisis  ·  Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

PhaseN/A
Planned participants3500
Who can joinAll sexes, 2 Years to 90 Years
Healthy volunteersNo

About this study

This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be asked to return for additional testing as needed. Clinical care for patients with sickle cell disease will be provided as appropriate through the Sickle Cell Clinic and the inpatient clinical center....

This description comes directly from the study's public registry record.

Talk to the study team

Nancy A Asomaning  ·  (301) 605-0398  ·  nancy.asomaning@nih.gov

Always discuss trial participation with your own doctor first.

Locations (3)

Childrens National Health CenterWashington D.C., District of Columbia, United StatesRecruiting
Suburban HospitalBethesda, Maryland, United StatesCompleted
National Institutes of Health Clinical CenterBethesda, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00081523